• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
M7T
Click for more information
1.39% 35.5¢

MACH7 TECHNOLOGIES LIMITED - Announcements

Market Cap $127.8M  ! watchlist Created with Sketch. Add to my watchlist

Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The... Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The principal activity of the Company is the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution consists of a Vendor Neutral Archive (VNA) and data administration tools, which allow for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the cloud. Enterprise Diagnostic Viewing offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. It offers its solutions across North America, Asia Pacific, and the Middle East region.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
M7T FY2017 Appendix 4E and Financial ReportPRICE SENSITIVE28/08/17
M7T Appendix 4C - quarterlyPRICE SENSITIVE17/07/17
M7T Appointment of Chief Executive OfficerPRICE SENSITIVE10/07/17
M7T Change of Registered Office07/07/17
M7T Becoming a substantial holder26/06/17
M7T Prominent USA Radiology Group Selects Mach7PRICE SENSITIVE26/06/17
M7T Ceasing to be a substantial holder from SOL21/06/17
M7T Ceasing to be a substantial holder20/06/17
M7T Release of securities from voluntary escrow16/06/17
M7T Mach7 Company UpdatePRICE SENSITIVE02/06/17
M7T Final Director's Interest Notice02/06/17
M7T Release of securities from voluntary escrow18/05/17
M7T Company UpdatePRICE SENSITIVE26/04/17
M7T Appendix 4C - quarterlyPRICE SENSITIVE26/04/17
M7T Ceasing to be a substantial holder - M7T11/04/17
M7T Appendix 3B - Release of Shares from Escrow10/04/17
M7T Conclusion of Unmarketable Parcel Share Sale Facility07/04/17
M7T Release of securities from escrow27/03/17
M7T Ceasing to be a substantial holder24/03/17
M7T Change of Director's Interest Notice x 216/03/17
M7T Resignation of Managing DirectorPRICE SENSITIVE16/03/17
M7T Cleansing notice10/03/17
M7T Appendix 3B10/03/17
M7T Becoming a substantial holder from SOL06/03/17
M7T Half Yearly Results Announcement27/02/17
M7T Appendix 4D and Half Yearly ReportPRICE SENSITIVE27/02/17
M7T Change in substantial holding - M7T22/02/17
M7T Cleansing notice20/02/17
M7T Appendix 3B20/02/17
M7T Mach7 on track to reach profitability in FY17PRICE SENSITIVE13/02/17
M7T Share Sale Facility for Unmarketable Parcel Holders10/02/17
M7T Release of shares from escrow and expiry of options06/02/17
M7T Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
M7T Appendix 3B - Issue of Employee LTIP Options27/01/17
M7T Post-Consolidation Capital Structure18/01/17
M7T Completion of share consolidation16/01/17
M7T Change in substantial holding05/01/17
M7T Change in substantial holding - M7T28/12/16
M7T Change of Director's Interest Notice x 528/12/16
M7T Cleansing Notice28/12/16
M7T Appendix 3B28/12/16
M7T Update - Consolidation/Split - M7T28/12/16
M7T Results of Extraordinary General Meeting28/12/16
M7T Change in substantial holding28/12/16
M7T Release of shares from voluntary escrow16/12/16
M7T Change in substantial holding - M7T15/12/16
M7T Change of Director's Interest Notice12/12/16
M7T Cleansing notice09/12/16
M7T Appendix 3B09/12/16
M7T Results of 2016 Annual General Meeting07/12/16
M7T Presentation to Shareholders at 2016 AGMPRICE SENSITIVE07/12/16
M7T Chairman's Address to Shareholders at 2016 AGM07/12/16
M7T Consolidation/Split - M7T29/11/16
M7T Notice of Extraordinary General Meeting and Proxy FormPRICE SENSITIVE28/11/16
M7T Change in substantial holding - BV Healthcare23/11/16
M7T Change in substantial holding - M7T23/11/16
M7T Cleansing notice22/11/16
M7T Appendix 3B22/11/16
M7T Becoming a substantial holder from HHL21/11/16
M7T Cleansing notice18/11/16
M7T Appendix 3B18/11/16
M7T Approval of extension of time to hold 2016 AGM18/11/16
M7T Release of shares from voluntary escrow16/11/16
M7T Mach7 Successfully Completes $9 Million Capital RaisePRICE SENSITIVE16/11/16
M7T Trading HaltPRICE SENSITIVE14/11/16
M7T Mach7 Awarded UK NHS Approved Supplier StatusPRICE SENSITIVE09/11/16
M7T Notice of Annual General Meeting/Proxy Form07/11/16
M7T Appendix 4G and Corporate Governance Statement-M7T.AX 20/10/16
M7T Annual Report to shareholders-M7T.AX 20/10/16
M7T Investor Presentation and Company Update-M7T.AX 12/10/16
M7T Appendix 4C - quarterly-M7T.AX PRICE SENSITIVE12/10/16
M7T Microsoft Partnership for Enterprise Imaging Cloud Solution-M7T.AX PRICE SENSITIVE05/10/16
M7T Letter to Shareholders-M7T.AX 19/09/16
M7T Mach7 Technologies Completes Major Implementation in Qatar-M7T.AX PRICE SENSITIVE06/09/16
M7T Cleansing Notice-M7T.AX 02/09/16
M7T Appendix 3B-M7T.AX 02/09/16
M7T FY2016 Appendix 4E and Financial Report-M7T.AX PRICE SENSITIVE01/09/16
M7T M7T awarded 2nd US Patent for Mobile Device Image Capture-M7T.AX PRICE SENSITIVE28/08/16
M7T M7T awarded 2nd US Patent for Mobile Device Image Capture-M7T.AX PRICE SENSITIVE25/08/16
M7T Mach7 Selected by Large US Healthcare Network-M7T.AX PRICE SENSITIVE18/08/16
M7T Appendix 3B - Exercise of Options-M7T.AX 16/08/16
M7T Mach7 Signs Distribution Agreement in United Kingdom-M7T.AX PRICE SENSITIVE09/08/16
M7T Mach7 Signs Distribution Agreement in Europe-M7T.AX PRICE SENSITIVE04/08/16
M7T Market Update-M7T.AX 03/08/16
M7T Mach7 Selected by Large U.S. University Medical Centre-M7T.AX PRICE SENSITIVE02/08/16
M7T Change of Director's Interest Notice-M7T.AX 01/08/16
M7T Appendix 3B - Exercise of Options-M7T.AX 01/08/16
M7T Appendix 4C - quarterly-M7T.AX PRICE SENSITIVE29/07/16
M7T Change of Director's Interest Notice-M7T.AX 28/06/16
M7T Initial Director's Interest Notice-M7T.AX 17/06/16
M7T Final Director's Interest Notice-M7T.AX 17/06/16
M7T Director Appointment and Resignation-M7T.AX 15/06/16
M7T Release of Ordinary Shares from Escrow-M7T.AX 10/06/16
M7T Ceasing to be a substantial holder-M7T.AX 09/06/16
M7T M7T named as leader in US healthcare provider VNA platforms-M7T.AX 08/06/16
M7T Becoming a substantial holder - M7T-M7T.AX 06/06/16
M7T Becoming a substantial holder-M7T.AX 06/06/16
M7T Cleansing notice-M7T.AX 31/05/16
M7T Appendix 3B-M7T.AX 31/05/16
M7T Investor Presentation-M7T.AX 25/05/16
M7T FY2017 Appendix 4E and Financial Report
28/08/17PRICE SENSITIVE
M7T Appendix 4C - quarterly
17/07/17PRICE SENSITIVE
M7T Appointment of Chief Executive Officer
10/07/17PRICE SENSITIVE
M7T Change of Registered Office
07/07/17
M7T Becoming a substantial holder
26/06/17
M7T Prominent USA Radiology Group Selects Mach7
26/06/17PRICE SENSITIVE
M7T Ceasing to be a substantial holder from SOL
21/06/17
M7T Ceasing to be a substantial holder
20/06/17
M7T Release of securities from voluntary escrow
16/06/17
M7T Mach7 Company Update
02/06/17PRICE SENSITIVE
M7T Final Director's Interest Notice
02/06/17
M7T Release of securities from voluntary escrow
18/05/17
M7T Company Update
26/04/17PRICE SENSITIVE
M7T Appendix 4C - quarterly
26/04/17PRICE SENSITIVE
M7T Ceasing to be a substantial holder - M7T
11/04/17
M7T Appendix 3B - Release of Shares from Escrow
10/04/17
M7T Conclusion of Unmarketable Parcel Share Sale Facility
07/04/17
M7T Release of securities from escrow
27/03/17
M7T Ceasing to be a substantial holder
24/03/17
M7T Change of Director's Interest Notice x 2
16/03/17
M7T Resignation of Managing Director
16/03/17PRICE SENSITIVE
M7T Cleansing notice
10/03/17
M7T Appendix 3B
10/03/17
M7T Becoming a substantial holder from SOL
06/03/17
M7T Half Yearly Results Announcement
27/02/17
M7T Appendix 4D and Half Yearly Report
27/02/17PRICE SENSITIVE
M7T Change in substantial holding - M7T
22/02/17
M7T Cleansing notice
20/02/17
M7T Appendix 3B
20/02/17
M7T Mach7 on track to reach profitability in FY17
13/02/17PRICE SENSITIVE
M7T Share Sale Facility for Unmarketable Parcel Holders
10/02/17
M7T Release of shares from escrow and expiry of options
06/02/17
M7T Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
M7T Appendix 3B - Issue of Employee LTIP Options
27/01/17
M7T Post-Consolidation Capital Structure
18/01/17
M7T Completion of share consolidation
16/01/17
M7T Change in substantial holding
05/01/17
M7T Change in substantial holding - M7T
28/12/16
M7T Change of Director's Interest Notice x 5
28/12/16
M7T Cleansing Notice
28/12/16
M7T Appendix 3B
28/12/16
M7T Update - Consolidation/Split - M7T
28/12/16
M7T Results of Extraordinary General Meeting
28/12/16
M7T Change in substantial holding
28/12/16
M7T Release of shares from voluntary escrow
16/12/16
M7T Change in substantial holding - M7T
15/12/16
M7T Change of Director's Interest Notice
12/12/16
M7T Cleansing notice
09/12/16
M7T Appendix 3B
09/12/16
M7T Results of 2016 Annual General Meeting
07/12/16
M7T Presentation to Shareholders at 2016 AGM
07/12/16PRICE SENSITIVE
M7T Chairman's Address to Shareholders at 2016 AGM
07/12/16
M7T Consolidation/Split - M7T
29/11/16
M7T Notice of Extraordinary General Meeting and Proxy Form
28/11/16PRICE SENSITIVE
M7T Change in substantial holding - BV Healthcare
23/11/16
M7T Change in substantial holding - M7T
23/11/16
M7T Cleansing notice
22/11/16
M7T Appendix 3B
22/11/16
M7T Becoming a substantial holder from HHL
21/11/16
M7T Cleansing notice
18/11/16
M7T Appendix 3B
18/11/16
M7T Approval of extension of time to hold 2016 AGM
18/11/16
M7T Release of shares from voluntary escrow
16/11/16
M7T Mach7 Successfully Completes $9 Million Capital Raise
16/11/16PRICE SENSITIVE
M7T Trading Halt
14/11/16PRICE SENSITIVE
M7T Mach7 Awarded UK NHS Approved Supplier Status
09/11/16PRICE SENSITIVE
M7T Notice of Annual General Meeting/Proxy Form
07/11/16
M7T Appendix 4G and Corporate Governance Statement-M7T.AX
20/10/16
M7T Annual Report to shareholders-M7T.AX
20/10/16
M7T Investor Presentation and Company Update-M7T.AX
12/10/16
M7T Appendix 4C - quarterly-M7T.AX
12/10/16PRICE SENSITIVE
M7T Microsoft Partnership for Enterprise Imaging Cloud Solution-M7T.AX
05/10/16PRICE SENSITIVE
M7T Letter to Shareholders-M7T.AX
19/09/16
M7T Mach7 Technologies Completes Major Implementation in Qatar-M7T.AX
06/09/16PRICE SENSITIVE
M7T Cleansing Notice-M7T.AX
02/09/16
M7T Appendix 3B-M7T.AX
02/09/16
M7T FY2016 Appendix 4E and Financial Report-M7T.AX
01/09/16PRICE SENSITIVE
M7T M7T awarded 2nd US Patent for Mobile Device Image Capture-M7T.AX
28/08/16PRICE SENSITIVE
M7T M7T awarded 2nd US Patent for Mobile Device Image Capture-M7T.AX
25/08/16PRICE SENSITIVE
M7T Mach7 Selected by Large US Healthcare Network-M7T.AX
18/08/16PRICE SENSITIVE
M7T Appendix 3B - Exercise of Options-M7T.AX
16/08/16
M7T Mach7 Signs Distribution Agreement in United Kingdom-M7T.AX
09/08/16PRICE SENSITIVE
M7T Mach7 Signs Distribution Agreement in Europe-M7T.AX
04/08/16PRICE SENSITIVE
M7T Market Update-M7T.AX
03/08/16
M7T Mach7 Selected by Large U.S. University Medical Centre-M7T.AX
02/08/16PRICE SENSITIVE
M7T Change of Director's Interest Notice-M7T.AX
01/08/16
M7T Appendix 3B - Exercise of Options-M7T.AX
01/08/16
M7T Appendix 4C - quarterly-M7T.AX
29/07/16PRICE SENSITIVE
M7T Change of Director's Interest Notice-M7T.AX
28/06/16
M7T Initial Director's Interest Notice-M7T.AX
17/06/16
M7T Final Director's Interest Notice-M7T.AX
17/06/16
M7T Director Appointment and Resignation-M7T.AX
15/06/16
M7T Release of Ordinary Shares from Escrow-M7T.AX
10/06/16
M7T Ceasing to be a substantial holder-M7T.AX
09/06/16
M7T M7T named as leader in US healthcare provider VNA platforms-M7T.AX
08/06/16
M7T Becoming a substantial holder - M7T-M7T.AX
06/06/16
M7T Becoming a substantial holder-M7T.AX
06/06/16
M7T Cleansing notice-M7T.AX
31/05/16
M7T Appendix 3B-M7T.AX
31/05/16
M7T Investor Presentation-M7T.AX
25/05/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
35.5¢ 		Change
-0.005(1.39%) 		Mkt cap ! $127.8M
Open High Low Value Volume
35.5¢ 35.8¢ 35.0¢ $163.8K 461.2K

Buyers (Bids)

No. Vol. Price($)
17 203974 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 68677 4
View Market Depth
Last trade - 15.51pm 21/11/2024 (20 minute delay) ?
Last
35.5¢ 		  Change
-0.005 ( 0.00 %)
Open High Low Volume
35.5¢ 35.5¢ 35.0¢ 42450
Last updated 15.51pm 21/11/2024 ?
M7T (ASX) Chart

Top Stories

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024 The ASX 200 is tipped to rise as much as 1% at open today after Wall Street enjoyed another major @Trump trade” surge buoyed by year-end optimism.The Dow Jones leaped 1.06% amid the U.S. jump, with the S@P 500 following close behind with a 0.53% rise @ a trend the Aussie bou...
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.